Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	98
Overall Study	STARTED	Bremelanotide Arm 1	100
Overall Study	STARTED	Bremelanotide Arm 2	100
Overall Study	STARTED	Bremelanotide Arm 3	99
Overall Study	Subjects Not Dosed	Placebo	1
Overall Study	Subjects Not Dosed	Bremelanotide Arm 1	0
Overall Study	Subjects Not Dosed	Bremelanotide Arm 2	1
Overall Study	Subjects Not Dosed	Bremelanotide Arm 3	1
Overall Study	COMPLETED	Placebo	80
Overall Study	COMPLETED	Bremelanotide Arm 1	81
Overall Study	COMPLETED	Bremelanotide Arm 2	66
Overall Study	COMPLETED	Bremelanotide Arm 3	66
Overall Study	NOT COMPLETED	Placebo	18
Overall Study	NOT COMPLETED	Bremelanotide Arm 1	19
Overall Study	NOT COMPLETED	Bremelanotide Arm 2	34
Overall Study	NOT COMPLETED	Bremelanotide Arm 3	33

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01382719/flow